JP2020514278A5 - - Google Patents

Download PDF

Info

Publication number
JP2020514278A5
JP2020514278A5 JP2019534737A JP2019534737A JP2020514278A5 JP 2020514278 A5 JP2020514278 A5 JP 2020514278A5 JP 2019534737 A JP2019534737 A JP 2019534737A JP 2019534737 A JP2019534737 A JP 2019534737A JP 2020514278 A5 JP2020514278 A5 JP 2020514278A5
Authority
JP
Japan
Prior art keywords
group
acid
contrast agent
cancer
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019534737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514278A (ja
JP7784103B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/068025 external-priority patent/WO2018119313A1/en
Publication of JP2020514278A publication Critical patent/JP2020514278A/ja
Publication of JP2020514278A5 publication Critical patent/JP2020514278A5/ja
Priority to JP2022207606A priority Critical patent/JP7680759B2/ja
Priority to JP2025075768A priority patent/JP2025118743A/ja
Application granted granted Critical
Publication of JP7784103B2 publication Critical patent/JP7784103B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019534737A 2016-12-23 2017-12-21 Pd-l1発現に基づく腫瘍および免疫細胞イメージング Active JP7784103B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022207606A JP7680759B2 (ja) 2016-12-23 2022-12-23 Pd-l1発現に基づく腫瘍および免疫細胞イメージング
JP2025075768A JP2025118743A (ja) 2016-12-23 2025-04-30 Pd-l1発現に基づく腫瘍および免疫細胞イメージング

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662438575P 2016-12-23 2016-12-23
US62/438,575 2016-12-23
US201762519534P 2017-06-14 2017-06-14
US62/519,534 2017-06-14
PCT/US2017/068025 WO2018119313A1 (en) 2016-12-23 2017-12-21 Tumor and immune cell imaging based on pd-l1 expression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022207606A Division JP7680759B2 (ja) 2016-12-23 2022-12-23 Pd-l1発現に基づく腫瘍および免疫細胞イメージング

Publications (3)

Publication Number Publication Date
JP2020514278A JP2020514278A (ja) 2020-05-21
JP2020514278A5 true JP2020514278A5 (https=) 2021-01-14
JP7784103B2 JP7784103B2 (ja) 2025-12-11

Family

ID=62627749

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019534737A Active JP7784103B2 (ja) 2016-12-23 2017-12-21 Pd-l1発現に基づく腫瘍および免疫細胞イメージング
JP2022207606A Active JP7680759B2 (ja) 2016-12-23 2022-12-23 Pd-l1発現に基づく腫瘍および免疫細胞イメージング
JP2025075768A Pending JP2025118743A (ja) 2016-12-23 2025-04-30 Pd-l1発現に基づく腫瘍および免疫細胞イメージング

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022207606A Active JP7680759B2 (ja) 2016-12-23 2022-12-23 Pd-l1発現に基づく腫瘍および免疫細胞イメージング
JP2025075768A Pending JP2025118743A (ja) 2016-12-23 2025-04-30 Pd-l1発現に基づく腫瘍および免疫細胞イメージング

Country Status (11)

Country Link
US (1) US11607466B2 (https=)
EP (1) EP3558395A4 (https=)
JP (3) JP7784103B2 (https=)
KR (2) KR102662725B1 (https=)
CN (1) CN110366432A (https=)
AU (1) AU2017382282B9 (https=)
BR (1) BR112019012986A2 (https=)
CA (1) CA3048229A1 (https=)
IL (1) IL267572B2 (https=)
MX (1) MX2019007615A (https=)
WO (1) WO2018119313A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
CN109512798B (zh) * 2019-01-15 2022-05-13 南京从一医药科技有限公司 一种用于抗肿瘤免疫治疗的药物组合物纳米体系
CN111662270A (zh) * 2019-03-05 2020-09-15 中国医学科学院药物研究所 碘同位素标记苄苯醚衍生物、及其制法和药物组合物与用途
CN110898234B (zh) * 2019-12-25 2020-12-22 河南大学 一种二维铋纳米复合材料及其制备方法和应用
TWI833056B (zh) 2019-12-31 2024-02-21 財團法人工業技術研究院 核酸藥物複合體以及其用途
CN112067586B (zh) * 2020-06-24 2021-08-03 江南大学 一种基于荧光淬灭拉曼增强的前列腺特异性抗原双信号光谱分析方法
CA3188677A1 (en) * 2020-08-07 2022-02-10 Sridhar Nimmagadda Imaging and targeting programmed death ligand-1 (pd-li) expression
DE102020130954A1 (de) 2020-11-23 2022-05-25 Universität Duisburg-Essen Markierungspartikel für Raman-Streuung und/oder Fluoreszenz-Strahlung
CN114853851B (zh) * 2021-02-04 2023-08-15 南方医科大学南方医院 靶向pd-l1多肽探针及其在制备pet显像剂中的应用
CN113341023B (zh) * 2021-06-30 2022-12-23 大连医科大学附属第一医院 一种基于液质联用的血清二氨基庚二酸的检测试剂盒及检测方法与应用
WO2023014999A1 (en) * 2021-08-06 2023-02-09 The Johns Hopkins University Aluminum fluoride radiosynthesis of [18f]dk222
CN115364247A (zh) * 2021-09-15 2022-11-22 中国人民解放军海军军医大学第一附属医院 一种靶向显影剂、制备方法及其应用
CN114010655B (zh) * 2021-11-02 2023-02-03 安徽医科大学第一附属医院 一种识别和降解前列腺癌细胞表面的pd-l1的金纳米星及其制备方法和应用
CN114569745A (zh) * 2022-03-18 2022-06-03 哈尔滨医科大学 一种靶向pd-l1的多肽pet分子成像探针及其制备方法与应用
AU2024344671A1 (en) * 2023-09-20 2026-03-26 Trimt Gmbh Functionalized peptides for in-vivo addressing of pd-l1 expression

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542371A (en) * 2003-03-19 2008-10-31 Universitatsspital Basel Radiolabeled conjugates based on substance P and the uses thereof
AU2009333580B2 (en) 2008-12-09 2016-07-07 Genentech, Inc. Anti-PD-L1 antibodies and their use to enhance T-cell function
WO2012074840A2 (en) * 2010-11-22 2012-06-07 The General Hospital Corporation Compositions and methods for in vivo imaging
US20140316255A1 (en) * 2011-09-02 2014-10-23 Ellis Garai Raman Imaging Devices and Methods of Molecular Imaging
US11268958B2 (en) * 2012-09-14 2022-03-08 The Johns Hopkins University Bacteria-specific labeled substrtates as imaging biomarkers to diagnose, locate, and monitor infections
US9308236B2 (en) 2013-03-15 2016-04-12 Bristol-Myers Squibb Company Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
TN2017000084A1 (en) * 2014-09-11 2018-07-04 Bristol Myers Squibb Co Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions
ES2981335T3 (es) * 2014-11-25 2024-10-08 Bristol Myers Squibb Co Novedosos polipéptidos de unión a PD-L1 para obtención de imágenes
US9861680B2 (en) 2014-12-18 2018-01-09 Bristol-Myers Squibb Company Immunomodulators
US9944678B2 (en) 2014-12-19 2018-04-17 Bristol-Myers Squibb Company Immunomodulators
US20160222060A1 (en) 2015-02-04 2016-08-04 Bristol-Myers Squibb Company Immunomodulators
HUE054306T2 (hu) * 2016-05-19 2021-08-30 Bristol Myers Squibb Co Immunmodulátorok PET-képalkotás számára
CN107869033B (zh) * 2016-09-26 2020-10-02 青岛胶南海尔洗衣机有限公司 一种干衣机用正反转风扇及干衣机

Similar Documents

Publication Publication Date Title
JP2020514278A5 (https=)
Shi et al. Review on near-infrared heptamethine cyanine dyes as theranostic agents for tumor imaging, targeting, and photodynamic therapy
Abadjian et al. Imaging the tumor microenvironment
Ju et al. Amine-functionalized lanthanide-doped KGdF4 nanocrystals as potential optical/magnetic multimodal bioprobes
Jennings et al. ‘Two is better than one’—probes for dual-modality molecular imaging
AU2012253502B2 (en) Carbonic anhydrase targeting agents and methods of using same
US20220211680A1 (en) Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
Cai et al. Near‐infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases
US20210275698A1 (en) Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
TW201825121A (zh) 抑制劑—功能化超微小奈米粒子及其方法
AU2013303233C1 (en) Prostate specific antigen agents and methods of using same for prostate cancer imaging
US20170314056A1 (en) Method of using near infrared fluorescent dyes for imaging and targeting cancers
JP2025118743A5 (https=)
CN105339436B (zh) 4,4-二取代环己基桥连七甲川花菁染料及其应用
Moussaron et al. Ultrasmall nanoplatforms as calcium‐responsive contrast agents for magnetic resonance imaging
Harrison et al. A multimeric MR-optical contrast agent for multimodal imaging
JP2016521254A (ja) invitroおよびinvivoイメージングおよび検出のための置換シラキサンテニウム赤色〜近赤外蛍光色素
CN104245954A (zh) 细菌成像剂及其使用方法
WO2007088129A2 (en) Cyanine dye compounds linked to metal chelator for bi-modal diagnostic imaging
EP3169336A1 (en) Compositions for targeting macrophages and other cd206 high expressing cells and methods of treating and diagnosis
Cohen et al. TSPO-targeted PET and optical probes for the detection and localization of premalignant and malignant pancreatic lesions
Samadzadeh et al. Molecular imaging using (nano) probes: cutting-edge developments and clinical challenges in diagnostics
Shimizu et al. Development of novel nanocarrier-based near-infrared optical probes for in vivo tumor imaging
WO2010054330A2 (en) Monofunctional carbocyanine dyes for in vivo and in vitro imaging
Niu et al. Quantum dots based near-infrared fluorescent probe for the detection of PepT1 expression in colorectal cancer